Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;46(3):610-621.
doi: 10.1111/jcpt.13369. Epub 2021 Feb 3.

Meropenem use and therapeutic drug monitoring in clinical practice: a literature review

Affiliations

Meropenem use and therapeutic drug monitoring in clinical practice: a literature review

Nadine A Steffens et al. J Clin Pharm Ther. 2021 Jun.

Abstract

What is known and objective: Meropenem, a carbapenem antibiotic, is widely prescribed for the treatment of life-threatening infections. The main parameter associated with its therapeutic success is the percentage of time that the levels remain above the minimum inhibitory concentration. Inadequate levels of meropenem can lead to therapeutic failure and increase the possibility of microbial resistance. The employment of strategies involving dose regimens and drug pharmacodynamics has become increasingly important to optimize therapies. In the present study, we conducted a review with the purpose of assembling information about the clinical use of meropenem and therapeutic drug monitoring.

Methods: A literature review emphasizing the application of therapeutic drug monitoring (TDM) of meropenem in clinical practice has been done. To identify articles related to the topic, we performed a standardized search from January 21, 2020 to December 21, 2020, using specific descriptors in PubMed, Lilacs and Embase.

Results and discussion: In total, 35 studies were included in the review. The daily dose of meropenem commonly ranged from 3 to 6 g/day. Critically ill patients and those with impaired renal function appear to be the most suitable patients for the application of meropenem TDM, in order to guide therapy. We observed that most of the studies recommend TDM and that, in nine locations, the TDM of meropenem and of other beta-lactams is a routine practice. TDM data can help to maximize the clinical outcomes of the treatment with meropenem. It can also improve the patient care by providing suitable levels of meropenem, guiding the most appropriate dose regimens, which is the main parameter associated with therapeutic success.

What is new and conclusion: The findings from this review suggest that the therapeutic monitoring of meropenem can be beneficial, since it adjusts the treatment and aids clinical outcomes. It does so by indicating the appropriate dosage and preventing failure, toxicity and possible antimicrobial resistance. The multidisciplinary effort, basic knowledge and communication among the medical team are also essential.

Keywords: TDM; antibiotics; clinical practice; infection.

PubMed Disclaimer

References

REFERENCES

    1. Gonçalves-Pereira J, Póvoa P. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams. Crit Care. 2011;15(5):R206. https://doi.org/10.1186/cc10441
    1. Simonato BS, Teixeira GC, Rebecca ESW, Ross C, Silva LDLd. Infusão contínua versus intermitente de meropenem na prática clínica [Continuous versus intermittent infusion of meropenem in clinical practice]. Arq Ciência Saúde UNIPAR. 2017;21(1):59-64. https://doi.org/10.25110/arqsaude.v21i1.2017.5389
    1. Streit F, Perl T, Schulze MH, Binder L. Personalised beta-lactam therapy: basic principles and practical approach. LaboratoriumsMedizin. 2016;40(6):385-397. https://doi.org/10.1515/labmed-2016-0050
    1. Nicolau DP. Pharmacokinetic and pharmacodynamic properties of meropenem. Clin Infect Dis. 2008;47(S1):S32-S40. https://doi.org/10.1086/590064
    1. Burger R, Guidi M, Calpini V, et al. Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections. J Antimicrob Chemother. 2018;73(12):3413-3422. https://doi.org/10.1093/jac/dky370

Publication types

LinkOut - more resources